↓ Skip to main content

Dove Medical Press

Article Metrics

New advances in the treatment of gout: review of pegloticase

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

patent
12 patents

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
49 Mendeley
Title
New advances in the treatment of gout: review of pegloticase
Published in
Therapeutics and Clinical Risk Management, October 2010
DOI 10.2147/tcrm.s6043
Pubmed ID
Authors

Mark Reinders

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
United States 1 2%
Unknown 46 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 22%
Student > Ph. D. Student 9 18%
Student > Master 8 16%
Student > Bachelor 5 10%
Professor > Associate Professor 4 8%
Other 9 18%
Unknown 3 6%
Readers by discipline Count As %
Medicine and Dentistry 17 35%
Agricultural and Biological Sciences 9 18%
Biochemistry, Genetics and Molecular Biology 8 16%
Chemistry 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 6 12%
Unknown 4 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#2,983,743
of 21,223,235 outputs
Outputs from Therapeutics and Clinical Risk Management
#139
of 1,215 outputs
Outputs of similar age
#60,637
of 290,201 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 1 outputs
Altmetric has tracked 21,223,235 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,215 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,201 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them